Work

Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation

Year: 2013

Type: article

Source: Targeted Oncology

DOI: 10.1007/s11523-013-0266-9

Authors: Filip Janku, Jennifer J. Wheler, David S. Hong, Razelle Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute, National Center for Research Resources, NIH Clinical Center

Awards: G1826404230, Center for Clinical and Translational Sciences, Phase I Studies of Targeted Anti-Cancer Therapies, Cancer Center Support Grant

OpenAlex ID: W2064544592

FWCI: 0.535

Cites: 25

Cited by: 7

Related to: 10